Retrospective Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Mar 28, 2016; 22(12): 3392-3403
Published online Mar 28, 2016. doi: 10.3748/wjg.v22.i12.3392
Table 5 Recipient risk variables - n = 45 n (%)
ResultRange
Hepatitis-C13 (28.9)
Ethanol6 (13.3)
Alpha-1 antitrypsin9 (20.0)
Hepatitis B3 (6.7)
Hepatocellular carcinoma18 (40.0)
≥ 2 diagnoses21 (46.7)
MELD28.7 ± 5.617-40
Duct to duct anastamosis38 (84.4)
Cold-ischemia time (min)429.9 ± 127.360-660
Warm-ischemia time (min)35.4 ± 13.616-76
Total-ischemia time (min)465.6 ± 131.095-688